Showing results (61-70 of 95) with videos related to
Sort By:
Pageof 10
Antiviral Therapy|March 19, 2019
Molecular cloning and phenotypic analysis of drug-resistance mutants with relevant S-region variants of HBV for a patient during 189-month anti-HBV treatmentYan Liu, Chunchen Wu, Rongjuan Chen, et al.Microbial Drug Resistance (Larchmont, N.Y.)|October 30, 2016
Comparison of Detection Rate and Mutational Pattern of Drug-Resistant Mutations Between a Large Cohort of Genotype B and Genotype C Hepatitis B Virus-Infected Patients in North ChinaXiaodong Li, Yan Liu, Shaojie Xin, et al.Antiviral Research|February 24, 2019
Prevalence of the entecavir-resistance-inducing mutation rtA186T in a large cohort of Chinese hepatitis B virus patientsLujie Liu, Yan Liu, Rongjuan Chen, et al.Oncotarget|October 6, 2017
Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBsYan Qiao, Shanshan Lu, Zhihui Xu, et al.Scientific Reports|September 15, 2017
Bacterial distributions and prognosis of bloodstream infections in patients with liver cirrhosisYangxin Xie, Bo Tu, Zhe Xu, et al.Transfusion|February 26, 2017
Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North ChinaHao Liao, Yan Liu, Jianhong Chen, et al.Journal of Hematology & Oncology|November 8, 2021
N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancerSenxu Lu, Li Han, Xiaoyun Hu, et al.Antiviral Research|March 12, 2021
Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogsYan Liu, Rongjuan Chen, Wenhui Liu, et al.Antiviral Therapy|December 5, 2018
Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapyHao Liao, Yan Liu, Xiaodong Li, et al.Hepatology International|April 14, 2018
The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infectionFan Li, Xiaodong Li, Tao Yan, et al.Pageof 10